Scopus BioPharma (CE) Quote - SCPS

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.0003

Bid

0.00

Ask

0.00

Volume

140

0.0003 Day's Range 0.0003

0.000001 52 Week Range 0.0637

Market Cap

12.625k

Previous Close

0.0003

Open

0.0003

Last Trade

120

0.0003

Last Trade Time

Financial Volume

US$ 0

VWAP

0.0003

Average Volume (3m)

20,184

Shares Outstanding

42,084,264

Dividend Yield

PE Ratio

-0.62

Earnings Per Share (EPS)

-0.28

Revenue

Net Profit

-11.61M

Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need. We are currently focusing our development efforts on our immuno-oncology programs, which are conducted primarily through Duet BioTherapeutics Inc. (... Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need. We are currently focusing our development efforts on our immuno-oncology programs, which are conducted primarily through Duet BioTherapeutics Inc. (Duet), our majority-owned subsidiary. These programs include three distinctive complementary CpG-STAT3 inhibitors: Antisense ("DUET-101"); RNA silencing ("DUET-202"); and DNA-binding inhibitor ("DUET-301"). The Company may also seek to develop additional drug candidates and identify additional compelling technologies for potential acquisition, in-licensing and/or other similar transactions. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.scopusbiopharma.com

Headquarters

Wilmington, Delaware, USA

Founded

Scopus BioPharma Inc (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker SCPS. The last closing price for Scopus BioPharma (CE) was US$0. Over the last year, Scopus BioPharma (CE) shares have traded in a share price range of US$ 0.000001 to US$ 0.0637.

Scopus BioPharma (CE) currently has 42,084,264 shares outstanding. The market capitalization of Scopus BioPharma (CE) is US$12,625.28 . Scopus BioPharma (CE) has a price to earnings ratio (PE ratio) of -0.62.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0.0003	0.0003	0.0003	1957	0.0003	CS
4	-0.0002	-40	0.0005	0.0005	0.0003	36033	0.00030066	CS
12	0	0	0.0003	0.01	0.0001	20184	0.00031395	CS
26	0.0002	200	0.0001	0.01	1.0E-6	14546	0.0002923	CS
52	-0.0507	-99.4117647059	0.051	0.0637	1.0E-6	10287	0.01359073	CS
156	-0.0848	-99.6474735605	0.0851	0.156	1.0E-6	25460	0.07384781	CS
260	-0.0848	-99.6474735605	0.0851	0.156	1.0E-6	25460	0.07384781	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
KBNTKubient Inc (CE)	US$ 0.0003 (29,900.00%)	400
YAYOYayYo Inc (CE)	US$ 0.0002 (19,900.00%)	15.71k
NHIQNantHealth Inc (CE)	US$ 0.25 (12,400.00%)	1.12k
ARDSAridis Pharmaceuticals Inc (CE)	US$ 0.0001 (9,900.00%)	33.37k
NSTBNorthern Star Investment Corporation II (CE)	US$ 0.01 (9,900.00%)	300
CLVRClever Leaves Holdings Inc (CE)	US$ 0.0002 (-99.98%)	676
CITLFCritical Infrastructure Technologies Ltd (PK)	US$ 0.0001 (-99.96%)	500
RQHTFReliq Health Technologies Inc (CE)	US$ 0.000001 (-99.91%)	100
EORBFOrbite Technologies Inc (CE)	US$ 0.000001 (-99.69%)	95.8k
ANTHAnthera Pharmaceuticals Inc (CE)	US$ 0.000001 (-99.50%)	428
RDARRaadr Inc (PK)	US$ 0.0011 (29.41%)	407.34M
CMGRClubhouse Media Group Inc (PK)	US$ 0.0001 (0.00%)	304.71M
DPUIDiscount Print USA Inc (PK)	US$ 0.0003 (50.00%)	187.09M
HMBLHUMBL Inc (PK)	US$ 0.0003 (50.00%)	105.08M
DRNGDrone Guarder Inc (PK)	US$ 0.00025 (25.00%)	88.96M